Skip to main content

Beractant Side Effects

Medically reviewed by Drugs.com. Last updated on Apr 21, 2023.

Applies to beractant: intratracheal suspension.

Side effects include:

Transient bradycardia, oxygen desaturation, endotracheal tube reflux, pallor, vasoconstriction, hypotension, endotracheal tube blockage, hypertension, hypocarbia, hypercarbia, apnea.

For Healthcare Professionals

Applies to beractant: intratracheal suspension.

General

The most commonly reported adverse experiences were associated with the dosing procedure; transient bradycardia occurred with 11.9% of doses and oxygen desaturation occurred with 9.8% of doses.[Ref]

Cardiovascular

Very common (10% or more): Transient bradycardia (11.9%)

Uncommon (0.1% to 1%): Pallor, vasoconstriction, hypotension, hypertension, hypercarbia, hypocarbia

Frequency not reported: Tachycardia, ventricular tachycardia, aortic thrombosis, cardiac failure, cardio-respiratory arrest, increased apical pulse, persistent fetal circulation, air embolism, total anomalous pulmonary venous return[Ref]

Respiratory

Common (1% to 10%): Oxygen desaturation

Uncommon (0.1% to 1%): Apnea

Frequency not reported: Lung consolidation, blood from the endotracheal tube, deterioration after weaning, respiratory decompensation, subglottic stenosis, paralyzed diaphragm, respiratory failure[Ref]

Gastrointestinal

Uncommon (0.1% to 1%): Endotracheal tube reflux, endotracheal tube blockage

Frequency not reported: Abdominal distension, hemorrhage, intestinal perforations, volvulus, bowel infarct, feeding intolerance, stress ulcer[Ref]

Endocrine

Frequency not reported: Adrenal hemorrhage, inappropriate ADH secretion, hyperphosphatemia[Ref]

Hematologic

Frequency not reported: Coagulopathy, thrombocytopenia, disseminated intravascular coagulation[Ref]

Hepatic

Frequency not reported: Hepatic failure[Ref]

Musculoskeletal

Frequency not reported: Inguinal hernia[Ref]

Nervous system

Frequency not reported: Seizures[Ref]

Renal

Frequency not reported: Renal failure, hematuria[Ref]

References

1. Product Information. Survanta Intratracheal (beractant). Abbott Pharmaceutical. 2002.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.

Some side effects may not be reported. You may report them to the FDA.

Medical Disclaimer